IMMUNOMEDICS INC 4 SEC Filings

Filed On	Filing
27 Oct 2020	Form 4: Fricker William, Principal Accounting Officer Disposed of 65,310 Stock Option (right to buy) (Disposition to Issuer)
23 Oct 2020	Form 4: Aghazadeh Behzad, Director and 1 other Returned 26,263,516 shares to the issuer · Disposed of 202,614 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 103,718 Restricted Stock Unit (Disposition to Issuer)
23 Oct 2020	Form 4: Malik Usama, Chief Fin. & Business Officer Returned 18,856 shares to the issuer · Disposed of 386,080 Stock Option (Right to Buy) (Disposition to Issuer)
23 Oct 2020	Form 4: Canute Scott A, Director Returned 13,516 shares to the issuer · Disposed of 155,286 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 3,718 Restricted Stock Unit (Disposition to Issuer)
23 Oct 2020	Form 4: Azelby Robert, Director Disposed of 29,040 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 3,718 Restricted Stock Unit (Disposition to Issuer)
23 Oct 2020	Form 4: Hutt Peter Barton, Director Returned 13,516 shares to the issuer · Disposed of 52,614 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 3,718 Restricted Stock Unit (Disposition to Issuer)
23 Oct 2020	Form 4: Itri Lorettta M, Chief Medical Officer Returned 15,000 shares to the issuer · Disposed of 200,000 Stock Option (Right to Buy) (Disposition to Issuer)
23 Oct 2020	Form 4: Andrews Kurt J., Chief Human Resources Officer Disposed of 238,072 Stock Option (Right to Buy) (Disposition to Issuer)
23 Oct 2020	Form 4: Islam Khalid, Director Returned 13,516 shares to the issuer · Disposed of 52,614 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 3,718 Restricted Stock Unit (Disposition to Issuer)
23 Oct 2020	Form 4: Ball Bryan, Chief Quality Officer Returned 10,000 shares to the issuer · Disposed of 261,937 Stock Option (Right to Buy) (Disposition to Issuer)
23 Oct 2020	Form 4: Freedberg Jared, Gen. Counsel & Corp. Secretary Disposed of 280,105 Stock Option (Right to Buy) (Disposition to Issuer)
23 Oct 2020	Form 4: Delaney Brendan, Chief Commercial Officer Disposed of 390,460 Stock Option (Right to Buy) (Disposition to Issuer)
23 Oct 2020	Form 4: Baum Charles M, Director Returned 9,667 shares to the issuer · Disposed of 46,117 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 3,718 Restricted Stock Unit (Disposition to Issuer)
23 Oct 2020	Form 4: Duncan Barbara Gayle, Director Returned 49,244 shares to the issuer · Disposed of 6,540 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 3,718 Restricted Stock Unit (Disposition to Issuer)
15 Sep 2020	Form 4: Duncan Barbara Gayle, Director Received 2,500 shares by exercise or conversion ($42.4K)
20 Aug 2020	Form 4: Duncan Barbara Gayle, Director Received 20,000 shares by exercise or conversion ($339K)
14 Aug 2020	Form 4: Duncan Barbara Gayle, Director Received 17,077 shares by exercise or conversion ($221K)
22 Jun 2020	Form 4: Aghazadeh Behzad, Director and 1 other Received 3,718 shares as a grant or award · Granted 6,540 Stock Option (right to buy)
22 Jun 2020	Form 4: Baum Charles M, Director Received 3,718 shares as a grant or award · Granted 6,540 Stock Option (right to buy)
22 Jun 2020	Form 4: Hutt Peter Barton, Director Received 3,718 shares as a grant or award · Granted 6,540 Stock Option (right to buy)

Comments